[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Editorial Board::
Executive Members::
Instruction to Authors::
Peer Review::
Articles Archive::
Indexing Databases::
Contact Us::
Site Facilities::
::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Volume 5, Issue 2 (Autumn & Winter 2003) ::
J Gorgan Univ Med Sci 2003, 5(2): 36-42 Back to browse issues page
Determination of P53 gene mutations in gastric cancer by PCR-SSCP
HR.Joshaghani (Ph.D) * 1, E.Koochaki (Ph.D) , R.Amini (Ph.D) , P.Derakhshandeh (Ph.D) , A.Ehsani (Ph.D) , M.Shabani (Ph.D) , M.Kadivar (M.D
Abstract:   (27119 Views)
Background & Objective: Gastric cancer is the 2nd cause of cancer mortality after lung cancer. Approximately 12% of all cancer death are due to gastric cancer. Tumorgenesis is thought to be a multistep process involving a series of genetic changes in oncogenes and suppressor genes. The most common cancer-related genetic change known in human tumors is P53 mutation, particularly in gastric cancer. This study was done to determine P53 gene mutations in gastric cancer. Materials & Methods: This study was performed on 44 biopsy from patients with gastric cancer during 2002 in 3 hospitals in Tehran. For determination of P53 gene mutations was performed PCR-SSCP methods. Results: The patients group comprised 31 males and 13 females (Average age, 60.8 years Ranging from 34 to 84 years). 36 cases (81.8%) intestinal type, 5 cases (11.4%) were diffuse type and 3 cases no defined. 44 gastric cancers of gastric tissues were screened for the mutations of P53 gene mutations in exons 5-8 using the PCR-SSCP analysis. After polyacrylamide gel electrophoresis, 9 patients (20.5%) showed an apparent electrophoretic mobility shift between the cancer and other normal samples. One mutation in exon 5 (11.1%), 2 were detected in exon 6 (22.2%), 3 were found in exon 7 (33.3%) and 3 were detected in exon 8 (33.3%). The mutation rate was 7 of 36 (21.2%) in intestinal type and 2 of (40%) in diffuse type. No significant correlation between P53 gene mutations and age and genus was found. Conclusion: This investigation showed the rate P53 gene mutation (20.5%) in gastric cancer in our society.
Keywords: Gastric cancer, Iran, P53 gene, Mutation, PCR-SSCP
Full-Text [PDF 221 kb]   (22127 Downloads)    
Type of Study: Original Articles | Subject: General
* Corresponding Author Address: Department of Medical Laboratory, Gorgan University of Medical Sciences. hr_joshaghani@yahoo.com


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

HR.Joshaghani (Ph.D), E.Koochaki (Ph.D), R.Amini (Ph.D), P.Derakhshandeh (Ph.D), A.Ehsani (Ph.D), M.Shabani (Ph.D) et al . Determination of P53 gene mutations in gastric cancer by PCR-SSCP . J Gorgan Univ Med Sci 2003; 5 (2) :36-42
URL: http://goums.ac.ir/journal/article-1-185-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 5, Issue 2 (Autumn & Winter 2003) Back to browse issues page
مجله دانشگاه علوم پزشکی گرگان Journal of Gorgan University of Medical Sciences
Persian site map - English site map - Created in 0.04 seconds with 36 queries by YEKTAWEB 4660
Creative Commons License
This work is licensed under a Creative Commons — Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)